2006
DOI: 10.1021/op0602270
|View full text |Cite
|
Sign up to set email alerts
|

Development of Practical Rhodium Phosphine Catalysts for the Hydrogenation of β-Dehydroamino Acid Derivatives

Abstract: The rhodium-catalyzed asymmetric hydrogenation of various β-dehydroamino acid derivatives to give optically active β-amino acids has been examined. Chiral monodentate 4,5-dihydro-3Hdinaphthophosphepines, which are easily tuned and accessible in a multi-10-g scale, have been used as ligands. The enantioselectivity is largely dependent on the nature of the substituent at the phosphorous atom and on the structure of the substrate. Applying optimized conditions up to 94% ee was achieved.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
11
0

Year Published

2008
2008
2019
2019

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 41 publications
(13 citation statements)
references
References 68 publications
2
11
0
Order By: Relevance
“…A linear correlation was found, which is indicative of the monoligated nature of the Pd complex involved in the enantiodetermining C−H activation step. 30,31 This would also be consistent with the experiment performed with precatalyst 7, which showed results similar to the corresponding in situ Pd/ligand mixture (Table 3, entry 10).…”
Section: ■ Mechanistic Considerationssupporting
confidence: 89%
“…A linear correlation was found, which is indicative of the monoligated nature of the Pd complex involved in the enantiodetermining C−H activation step. 30,31 This would also be consistent with the experiment performed with precatalyst 7, which showed results similar to the corresponding in situ Pd/ligand mixture (Table 3, entry 10).…”
Section: ■ Mechanistic Considerationssupporting
confidence: 89%
“…The least-substituted substrate methyl 2-(hydroxymethyl)acrylate (A; its product is also known as the Roche ester) [17] is used as a building block in the synthesis of the antitumor agents tedanolide and discodermolide. [18] The trisubstituted (unnatural) b-amino acid precursors (Z)methyl 3-acetamidobut-2-enoate (B) [19] and (E)-methyl 2-(acetamidomethyl)-3-phenylacrylate (C) [7j] are interesting building blocks for the synthesis of biologically active b-peptide chains, which are stable to proteolytic degradation. [20] Currently no efficient catalyst is reported to obtain C with high enantioselectivity.…”
Section: Resultsmentioning
confidence: 99%
“…As already mentioned before, we were not able to identify a suited asymmetric catalyst for our previous [4+1]‐annulation of o ‐QMs 2 . However, given the fact that p ‐QM 3 a performed very well in the racemic reaction and also allowed for a catalytic approach, we were confident that the well‐described bulky chiral phosphines A or B may allow for a truly catalytic enantioselective protocol (Table ). We first used the binaphthyl‐based phosphines A1 – 3 , but unfortunately neither of them allowed for any product formation (entries 1–3).…”
Section: Resultsmentioning
confidence: 99%